Atlas Trials

Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma

Clinical trial NCT03382522 · COMPLETED

Trial details

NCT number
NCT03382522
Sponsor
University Hospital, Brest
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2018-01-01
Primary completion
2018-03-30
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.